Multiple Sclerosis

Danial K. Hallam1

1 University of Washington, Seattle, Washington
Publication Name:  Current Protocols in Magnetic Resonance Imaging
Unit Number:  Unit A5.1
DOI:  10.1002/0471142719.mia0501s00
Online Posting Date:  May, 2001
GO TO THE FULL TEXT: PDF or HTML at Wiley Online Library


Although a routine brain MR exam would suffice in many applications, specific protocols for multiple sclerosis have been developed to maximize its contribution. This unit presents one such protocol while recognizing the wide opportunity for variation depending on local clinical demand and personal preference.

PDF or HTML at Wiley Online Library

Table of Contents

  • Basic Protocol 1: Multiple Sclerosis
  • Commentary
  • Figures
  • Tables
PDF or HTML at Wiley Online Library


Basic Protocol 1: Multiple Sclerosis

  • Normal saline (0.9% NaCl), sterile
  • Extravascular contrast agent (e.g., Magnevist, Omniscan, or Prohance)
PDF or HTML at Wiley Online Library



Literature Cited

Literature Cited
   Bastianello, S., Bozzao, A., Paolillo, A., Giugni, E., Gasperini, C., Koudriavtseva, T., Millefiorini, E., Horsfield, M.A., Colonnese, C., Toni, D., Fiorelli, M., Pozzilli, C., and Bozzao, L. 1997. Fast spin‐echo and fast fluid‐attenuated inversion‐recovery versus conventional spin‐echo sequences for MR quantification of multiple sclerosis lesions. Am. J. Neuroradiol. 18:699‐704.
   Bastianello, S., Gasperini, C., Paolillo, A., Giugni, E., Ciccarelli, O., Sormani, M.P., Horsfield, M.A., Rovaris, M., Pozzilli, C., and Filippi, M. 1998. Sensitivity of enhanced MR in multiple sclerosis: Effects of contrast dose and magnetization transfer contrast. Am. J. Neuroradiol. 19:1863‐1867.
   Filippi, M., Rovaris, M., Capra, R., Gasperini, C., Yousry, T.A., Sormani, M.P., Prandini, F., Horsfield, M.A., Martinelli, V., Bastianello, S., Kuhne, I., Pozzilli, C., and Comi, G. 1998a. A multi‐centre longitudinal study comparing the sensitivity of monthly MRI after standard and triple dose gadolinium‐DTPA for monitoring disease activity in multiple sclerosis. Implications for phase II clinical trials. Brain 121:2011‐2020.
   Filippi, M., Rovaris, M., Gasperini, C., Capra, R., Bastianello, S., Kuhne, I., and Yousry, T.A. 1998b. A preliminary study comparing the sensitivity of serial monthly enhanced MRI after standard and triple dose gadolinium‐DTPA for monitoring disease activity in primary progressive multiple sclerosis. Journal of Neuroimaging 8:88‐93.
   Finelli, D.A., Hurst, G.C., Gullapali, R.P., and Bellon, E.M. 1994. Improved contrast of enhancing brain lesions on postgadolinium, T1‐weighted spin‐echo images with use of magnetization transfer. Radiology 190:553‐559.
   Gean‐Marton, A.D., Vezina, L.G., Marton, K.I., Stimac, G.K., Peyster, R.G., Taveras, J.M., and Davis, K.R. 1991. Abnormal corpus callosum: A sensitive and specific indicator of multiple sclerosis. Radiology 180:215‐221.
   Giovannoni, G., Lai, M., Thorpe, J., Kidd, D., Chamoun, V., Thompson, A J., Miller, D.H., Feldmann, M., and Thompson, E.J. 1997. Longitudinal study of soluble adhesion molecules in multiple sclerosis: correlation with gadolinium enhanced magnetic resonance imaging. Neurology 48:1557‐1565.
   Giugni, E., Pozzilli, C., Bastianello, S., Gasperini, C., Paolillo, A., Koudriavtseva, T., Frontoni, M., Farina, D., and Bozzao, L. 1997. MRI measures and their relations with clinical disability in relapsing‐remitting and secondary progressive multiple sclerosis. Multiple Sclerosis 3:221‐225.
   Hajnal, J.V., Bryant, D.J., Kasuboski, L., Pattany, P.M., De Coene, B., Lewis, P.D., Pennock, J.M., Oatridge, A., Young, I.R., and Bydder, G. M. 1992. Use of fluid attenuated inversion recovery (FLAIR) pulse sequences in MRI of the brain. J. Comput. Assisted Tomogr. 16:841‐844.
   Hashemi, R.H., Bradley, W.G. Jr., Chen, D.Y., Jordan, J.E., Queralt, J.A., Cheng, A.E., and Henrie, J.N. 1995. Suspected multiple sclerosis: MR imaging with a thin‐section fast FLAIR pulse sequence. Radiology 196:505‐510.
   Hennig, J., Nauerth, A., and Friedburg, H. 1986. RARE imaging: A fast imaging method for clinical MR. Magn. Reson. Med. 3:823‐833.
   Jackson, A., Fitzgerald, J.B., and Gillespie, J.E. 1993. The callosal‐septal interface lesion in multiple sclerosis: Effect of sequence and imaging plane. Neuroradiology 35:573‐577.
   Katz, D., Taubenberger, J.K., Cannella, B., McFarlin, D.E., Raine, C.S., and McFarland, H.F. 1993. Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann. Neurol. 34:661‐669.
   Mehta, R.C., Pike, G.B., and Enzmann, D.R. 1995. Improved detection of enhancing and nonenhancing lesions of multiple sclerosis with magnetization transfer. Am. J. Neuroradiol. 16:1771‐1778.
   Mehta, R.C., Pike, G.B., and Enzmann, D.R. 1996. Measure of magnetization transfer in multiple sclerosis demyelinating plaques, white matter ischemic lesions, and edema. Am. J. Neuroradiol. 17:1051‐1055.
   Nesbit, G.M., Forbes, G.S., Scheithauer, B.W., Okazaki, H., and Rodriguez, M. 1991. Multiple sclerosis: Histopathologic and MR and/or CT correlation in 37 cases at biopsy and three cases at autopsy. Radiology 180:467‐474.
   Palmer, S., Bradley, W.G., Chen, D.Y., and Patel, S. 1999. Subcallosal striations: Early findings of multiple sclerosis on sagittal, thin‐section, fast FLAIR MR images. Radiology 210:149‐153.
   Rovaris, M., Mastronardo, G., Gasperini, C., Prandini, F., Yousry, T.A., and Filippi, M. 1998. MRI evolution of new MS lesions enhancing after different doses of gadolinium. Acta Neurol. Scand. 98:90‐93.
   Rovaris, M., Mastronardo, G., Prandini, F., Bastianello, S., Comi, G., and Filippi, M. 1999a. Short‐term evolution of new multiple sclerosis lesions enhancing on standard and triple dose gadolinium‐enhanced brain MRI scans. J. Neurol. Sci. 164:148‐152.
   Rovaris, M., Rodegher, M., Comi, G., and Filippi, M. 1999b. Correlation between MRI and short‐term clinical activity in multiple sclerosis: Comparison between standard‐ and triple‐dose Gd‐enhanced MRI. Eur. Neurol. 41:123‐127.
   Rydberg, J.N., Riederer, S.J., Rydberg, C.H., and Jack, C.R. 1995. Contrast optimization of fluid‐attenuated inversion recovery (FLAIR) imaging. Magn. Reson. Med. 34:868‐877.
   Shellock, F.G. 1996. Pocket Guide to MR Procedures and Metallic Objects. Lippincott‐Raven, Philadelphia.
   Silver, N.C., Good, C.D., Barker, G.J., MacManus, D.G., Thompson, A.J., Moseley, I.F., McDonald, W.I., and Miller, D.H. 1997. Sensitivity of contrast enhanced MRI in multiple sclerosis. Effects of gadolinium dose, magnetization transfer contrast and delayed imaging. Brain 120:1149‐1161.
   Thorpe, J.W., Halpin, S.F., MacManus, D.G., Barker, G.J., Kendall, B.E., and Miller, D.H. 1994. A comparison between fast and conventional spin‐echo in the detection of multiple sclerosis lesions. Neuroradiology 36:388‐392.
   Trojano, M., Avolio, C., Simone, I.L., Defazio, G., Manzari, C., De Robertis, F., Calo, A., and Livrea, P. 1996. Soluble intercellular adhesion molecule‐1 in serum and cerebrospinal fluid of clinically active relapsing‐remitting multiple sclerosis: correlation with Gd‐DTPA magnetic resonance imaging‐enhancement and cerebrospinal fluid findings. Neurology 47:1535‐1541.
   Truyen, L., Van Waesberghe, J.H., Van Walderveen, M.A., Van Oosten, B.W., Polman, C.H., Hommes, O.R., Ader, H.J., and Barkhof, F. 1996. Accumulation of hypointense lesions (“black holes”) on T1 spin‐echo MRI correlates with disease progression in multiple sclerosis. Neurology 47:1469‐1476.
   Tubridy, N., Barker, G.J., MacManus, D.G., Moseley, I.F., and Miller, D.H. 1998. Optimisation of unenhanced MRI for detection of lesions in multiple sclerosis: A comparison of five pulse sequences with variable slice thickness. Neuroradiology 40:293‐297.
   Van Walderveen, M.A., Barkhof, F., Hommes, O.R., Polman, C.H., Tobi, H., Frequin, S.T., and Valk, J. 1995. Correlating MRI and clinical disease activity in multiple sclerosis: Relevance of hypointense lesions on short‐TR/short‐TE (T1‐weighted) spin‐echo images. Neurology 45:1684‐1690.
   Wolff, S.D. and Balaban, R.S. 1989. Magnetization transfer contrast (MTC) and tissue water proton relaxation in vivo. Magn. Reson. Med. 10:135‐144.
Key References
   Shellock, 1996. See above.
  Covers a number of important patient management issues related to MR imaging, including recommended safety procedures, a list of metallic implants that have been tested for MR compatibility, and a list of other sources on MR safety.
PDF or HTML at Wiley Online Library